Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.94 USD | -1.54% | +6.62% | +54.46% |
May. 20 | Nurix Therapeutics Names New Board Chair | MT |
May. 14 | Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.46% | 946M | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-3.61% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- NRIX Stock
- News Nurix Therapeutics, Inc.
- Baird Adjusts Price Target on Nurix Therapeutics to $25 From $24, Maintains Outperform Rating